| Project/Area Number |
16H05416
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Okayama University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
香川 俊輔 岡山大学, 大学病院, 准教授 (00362971)
田澤 大 岡山大学, 大学病院, 准教授 (90415513)
|
|---|
| Project Period (FY) |
2016-04-01 – 2019-03-31
|
| Project Status |
Completed (Fiscal Year 2018)
|
| Budget Amount *help |
¥17,680,000 (Direct Cost: ¥13,600,000、Indirect Cost: ¥4,080,000)
Fiscal Year 2018: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2017: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2016: ¥9,360,000 (Direct Cost: ¥7,200,000、Indirect Cost: ¥2,160,000)
|
|---|
| Keywords | 癌 / 遺伝子 / 細胞・組織 / 医療・福祉 / トランスレーショナルリサーチ / トランス / トランスレーショナル・リサーチ / ﾄﾗﾝｽﾚｰｼｮﾅﾙ・ﾘｻｰﾁ |
|---|
| Outline of Final Research Achievements |
Peritoneal dissemination is the most common form of metastasis in gastrointestinal cancer, and is associated with an extremely poor prognosis. We developed a new approach to visualize floating tumor cells using a green fluorescent protein (GFP)-expressing attenuated adenovirus in which the telomerase promoter regulates viral replication (TelomeScan, OBP-401). Moreover, we used a unique TelomeScan derivative (TelomeScan-F45, OBP-1101) that have a strict replication control function by micro-RNA together with targeting properties through CD46; however, unfortunately, the combination strategy was not able to show the usefulness.
|
| Academic Significance and Societal Importance of the Research Achievements |
テロメラーゼ特異的蛍光標識ウイルス製剤TelomeScan（OBP-401）では、EpCAMなど上皮系マーカーを指標としたCellSearchシステムでは検出不能であった、より悪性化して上皮間葉転換（EMT）を生じたがん細胞も標識することができ、鋭敏で高精度な検出感度が確認できた。TelomeScan-F45（OBP-1101）を併用するデュアル体外診断システムの確立は困難であったが、TelomeScanによる臨床的に有用なプラットフォームは構築できたと考える。
|
